glp-1 weight loss drug news today 2025 Market Size, Share glp-1 weight loss drug news
Description
On one hand, their core customers are having a suboptimal experience accessing medication
The identification of subgroups that are most likely to benefit from GLP-1RAs could be guided by biomarkers, and cardiac imaging may help determine whether the advantages of GLP-1RAs extend beyond the metabolic or obesity phenotypes
Hughes S, Neumiller JJ
We spoke with Stanford Medicine clinicians who prescribe GLP-1s daily
Previous meta-analyses have indicated that tirzepatide might potentially decrease the risk of cardiovascular events by affecting cardiac cells, the pancreas, and other tissues directly and indirectly [2]
